Pulse.

a daily field guide to health research that matters

◆ Console

‹ back to Sat · 27 Jun 2026

Daily digest

Sat · 27 Jun 2026

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.

PubMed Daily Triage - 2026-06-27

Run status: SUCCESS
Window: 2026-06-26T00:00:00Z to 2026-06-27T23:59:59Z
Articles reviewed: 169 | HIGH: 14 | STANDARD: 62 | LOW: 93

High Priority

1. Circulating Cell-Free DNA Analysis for Diagnostic and Prognostic Assessment of Hepatocellular Carcinoma in Cirrhosis

PMID: 42353299 | Journal: International journal of molecular sciences | Score: 9/10 Topics: T3 - Early Cancer Detection

Circulating Cell-Free DNA Analysis for Diagnostic and Prognostic Assessment of Hepatocellular Carcinoma in Cirrhosis.

This cohort/real-world study was triaged for T3 - Early Cancer Detection based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.

2. Pola-R-CHP as frontline therapy for diffuse large B-cell lymphoma: a systematic review and meta-analysis of randomized trials and real-world evidence

PMID: 42362499 | Journal: Blood cancer journal | Score: 9/10 Topics: T1 - Hematologic Malignancies

Meta-analysis of randomized and real-world Pola-R-CHP evidence in frontline DLBCL.

This meta-analysis was triaged for T1 - Hematologic Malignancies based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with stronger evidence maturity.

3. OncoGen.AI: an integrated platform for automated genomic analysis and reporting in precision oncology

PMID: 42362719 | Journal: NPJ precision oncology | Score: 9/10 Topics: T5 - Precision Oncology/Genomic Medicine

OncoGen.AI: an integrated platform for automated genomic analysis and reporting in precision oncology.

This cohort/real-world study was triaged for T5 - Precision Oncology/Genomic Medicine based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.

4. Efficacy and safety of orforglipron in obesity with type 2 diabetes mellitus: a GRADE-assessed meta-analysis of randomized controlled trials

PMID: 42363271 | Journal: Diabetology & metabolic syndrome | Score: 9/10 Topics: T7 - Cardiovascular-metabolic GLP-1/SGLT2

GRADE-assessed meta-analysis of randomized orforglipron trials in obesity with type 2 diabetes.

This meta-analysis was triaged for T7 - Cardiovascular-metabolic GLP-1/SGLT2 based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with stronger evidence maturity.

5. Cell type-specific contextualisation of the human phenome: towards the systematic treatment of all rare diseases

PMID: 42363298 | Journal: Genome medicine | Score: 9/10 Topics: T9 - Rare Diseases

The article reports cell type-specific contextualisation of the human phenome: towards the systematic treatment of all rare diseases.

This diagnostic/model validation study was triaged for T9 - Rare Diseases based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.

6. Comparative Analysis of Serum and Tissue miRNA Expression Profiles and Regulatory Pathways in Early-Stage Ovarian Cancer Using Public Databases

PMID: 42353343 | Journal: International journal of molecular sciences | Score: 8/10 Topics: T3 - Early Cancer Detection

Comparative Analysis of Serum and Tissue miRNA Expression Profiles and Regulatory Pathways in Early-Stage Ovarian Cancer Using Public Databases.

This diagnostic/model validation study was triaged for T3 - Early Cancer Detection based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.

7. Frequency-Domain Transformation of cfDNA End-Motif Profiles Enhances Robust Cancer Detection

PMID: 42353820 | Journal: Genes | Score: 8/10 Topics: T3 - Early Cancer Detection

The article reports frequency-Domain Transformation of cfDNA End-Motif Profiles Enhances Robust Cancer Detection.

This journal article was triaged for T3 - Early Cancer Detection based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with limited evidence maturity.

8. Expanding the clinical and molecular spectrum of NGLY1 deficiency: A multicenter cohort

PMID: 42361657 | Journal: Molecular genetics and metabolism | Score: 8/10 Topics: T9 - Rare Diseases

Expanding the clinical and molecular spectrum of NGLY1 deficiency: A multicenter cohort.

This cohort/real-world study was triaged for T9 - Rare Diseases based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.

9. Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimetics

PMID: 42362999 | Journal: Nature cancer | Score: 8/10 Topics: T1 - Hematologic Malignancies

Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimetics.

This journal article was triaged for T1 - Hematologic Malignancies based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with limited evidence maturity.

10. Cell-free DNA dynamics and progression-free survival in metastatic gastroesophageal adenocarcinoma: insights from the REGIRI-PRODIGE 58 ancillary study

PMID: 42363005 | Journal: NPJ precision oncology | Score: 8/10 Topics: T3 - Early Cancer Detection

Cell-free DNA dynamics and progression-free survival in metastatic gastroesophageal adenocarcinoma: insights from the REGIRI-PRODIGE 58 ancillary study.

This cohort/real-world study was triaged for T3 - Early Cancer Detection based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.

11. Targeting CCR7-KMT2D enhances CAR-T cell efficacy by suppressing therapy-induced senescence in B-cell non-Hodgkin lymphoma

PMID: 42363110 | Journal: BMC medicine | Score: 8/10 Topics: T1 - Hematologic Malignancies

The article reports targeting CCR7-KMT2D enhances CAR-T cell efficacy by suppressing therapy-induced senescence in B-cell non-Hodgkin lymphoma.

This journal article was triaged for T1 - Hematologic Malignancies based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.

12. Next-generation of mesothelin-targeted CAR-T cells secreting anti-PD-L1 scFv for potent immunotherapy against 3D patient-derived colorectal cancer organoids

PMID: 42363170 | Journal: BMC medicine | Score: 8/10 Topics: T6 - Novel Therapeutics (immunotherapy/CAR-T)

The article reports next-generation of mesothelin-targeted CAR-T cells secreting anti-PD-L1 scFv for potent immunotherapy against 3D patient-derived colorectal cancer organoids.

This diagnostic/model validation study was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.

13. Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry study

PMID: 42363232 | Journal: Journal of hematology & oncology | Score: 8/10 Topics: T1 - Hematologic Malignancies

Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry study.

This cohort/real-world study was triaged for T1 - Hematologic Malignancies based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.

14. CT-based radiomics as a non-invasive virtual biopsy for high PD-L1 expression prediction in non-small cell lung cancer

PMID: 42363255 | Journal: Cancer imaging : the official publication of the International Cancer Imaging Society | Score: 8/10 Topics: T6 - Novel Therapeutics (immunotherapy/CAR-T)

The article reports cT-based radiomics as a non-invasive virtual biopsy for high PD-L1 expression prediction in non-small cell lung cancer.

This diagnostic/model validation study was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on abstract review. It appears high priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.

Standard Priority Watchlist

Topic Coverage

Files